{"title":"Persistent Diuresis Associated Dapagliflozin Treatment","authors":"A. Gülmez, Tuğba Kandemir Gülmez","doi":"10.5336/CASEREP.2018-61023","DOIUrl":null,"url":null,"abstract":"Diabetic ketoacidosis is a clinical entity characterized by high blood sugar, ketone positivity and high anion gap metabolic acidosis. In these patients; polyuria is commonly detected due to hyperglycemia. Polyuria-induced dehydration may even be seen, especially in elderly patients. Polyuria is not expected to continue after hyperglycemia has resolved. We reported in this article; a 55 years old man with type-2 diabetes mellitus who was treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor (dapagliflozin) who developed diabetic ketoacidosis and persistent diuresis in the post-treatment normoglycemic period.","PeriodicalId":23460,"journal":{"name":"Türkiye Klinikleri Journal of Case Reports","volume":"20 6 1","pages":"209-212"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Türkiye Klinikleri Journal of Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/CASEREP.2018-61023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic ketoacidosis is a clinical entity characterized by high blood sugar, ketone positivity and high anion gap metabolic acidosis. In these patients; polyuria is commonly detected due to hyperglycemia. Polyuria-induced dehydration may even be seen, especially in elderly patients. Polyuria is not expected to continue after hyperglycemia has resolved. We reported in this article; a 55 years old man with type-2 diabetes mellitus who was treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor (dapagliflozin) who developed diabetic ketoacidosis and persistent diuresis in the post-treatment normoglycemic period.